Topic: Europe

Three European companies douse hopes for new drugs

LONDON/PARIS (Reuters) - Three of Europe's biggest drugmakers -- AstraZeneca , Novartis and Sanofi -- reported product setbacks on Tuesday, underlining the difficulties of developing new medicines to make up for those going off patent.With the weakest pipeline of its European peers, ...

Analysis: Europe's crisis spells more pain for drugmakers

LONDON (Reuters) - Drugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France.Growing alarm at multiple government-imposed cuts prompted a frank letter from the CEO of GlaxoSmithKline, ...
Swiss pharmaceutical giant Novartis said on Tuesday it would slash 2,000 jobs, mostly in Switzerland and the United States, despite reporting third quarter net profits of $3.53 billion (2.5 billion euros).The firm said in a statement that profits for the quarter were ...

Novartis to cut 2,000 jobs to save annual $200 million

ZURICH (Reuters) - Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday.The Basel-based group has already ...

EU sets out tough rules on medicines information

LONDON (Reuters) - Europe will strictly limit the amount of information that drugmakers can supply to the public on prescription-only medicines and retain a ban on advertising under proposed rules set out on Tuesday.The latest proposals from the European Commission amend those ...

NICE seen at heart of new UK drug pricing system

LONDON (Reuters) - Britain's cost-effectiveness health watchdog NICE expects to play a central role in a value-based pricing system for new medicines due to take effect from 2014, according to its chief executive.After a government rethink last month, the National Institute for ...

Russian police search Novartis, Teva offices: report

MOSCOW (Reuters) - Russian police searched the offices of four pharmaceutical companies in Moscow on Tuesday, including Swiss drug maker Novartis AG and Israel-based Teva, the business daily Vedomosti reported, quoting a police source.Vedomosti, in a report on its website, quoted the ...

Top court rejects generic drug labeling suits

WASHINGTON (Reuters) - The Supreme Court ruled on Thursday that generic drug companies cannot be sued under state law over allegations that they failed to provide adequate label warnings about potential side effects.The justices handed a victory to Israel's Teva Pharmaceutical Industries ...

Pfizer to shut major British site, home of Viagra

LONDON (Reuters) - Pfizer Inc is to close its research and development center in Sandwich, southern England, which employs 2,400 people, dealing a major blow to Britain's scientific jobs base.The world's biggest drugmaker said on Tuesday it would exit the site over ...

EU regulator calls for more antibiotic research

LONDON (Reuters) - Drug companies are failing to put their research dollars into antibiotics and other key areas of unmet medical need, highlighting a mismatch between the hunt for profits and public health, Europe's top health regulator said.Thomas Lonngren, outgoing head of ...
Previous